One of the major objectives of the NIH-funded New Jersey Alliance for Clinical and Translational Science (NJ ACTS) is to successfully translate biomedical discoveries to clinical applications by promoting creative and innovative science, and by providing pilot support for hypothesis generation and testing, and building teams to address questions in translational science.
The NJ ACTS Pilot Program offers one year pilot grants to foster collaborative research among faculty in three institutions: Princeton University, New Jersey Institute of Technology (NJIT) and Rutgers University. We expect that the NJ ACTS Pilot Program will increase collaborative research and provide a path to sustainable, extramurally-funded independent research across the alliance.
NJ ACTS will commit up to $640,000 this year. The program is funded through the generous support of the NIH CTSA Award, the New Jersey Health Foundation (NJHF), and each of the academic partners.
Please review the NJ ACTS Request for Application (RFA) and fillable application found below. This year the rules and award categories have changed slightly. There are four different categories of projects and the collaboration requirements and funding amounts vary by project type. Translational and Clinical Sciences awards up to 110K are available, and awards of up to 50K are available in other categories. This is a good mechanism for funding a pilot project and might be appropriate for graduate students and postdocs to shoot for an award, with guidance from mentor(s).
If you have a question, please feel free to write to NJ ACTS or contact our NJ ACTS research coordinator, Bianca Freda at firstname.lastname@example.org. The leaders of the Pilot Program will host a webinar to explain the categories of funding, proposal requirements, regulatory requirements and NIH/NCATS approval processes, and to answer questions from participants.
Letter of Intent Deadline: March 19, 2021 (required)
Application Deadline: April 16, 2021